MGP Ingredients’ Deadline Rosen Recognized as Investor Counsel Encouraging Shareholder Action: A Detailed Analysis

Important Information for Investors of MGP Ingredients, Inc. (MGPI): Rosen Law Firm Announces Class Action Lawsuit and Lead Plaintiff Deadline Rosen Law Firm, a renowned global investor rights law firm, has recently announced that purchasers of MGP Ingredients, Inc. (MGPI) common stock between May 4, 2023, and October 30, 2024 (the “Class Period”), may be…

Read More

Revolutionizing Treatment for Dry AMD: Galimedix Therapeutics Launches Pivotal Phase 2 Trial with GAL-101 Eye Drops

Galimedix Therapeutics Announces Phase 2 Study for Treatment of Dry AMD Introduction In a recent press release, Galimedix Therapeutics, Inc. has announced the initiation of a Phase 2 study with GAL-101 eye drops for patients with dry age-related macular degeneration (dry AMD). This groundbreaking study aims to evaluate the efficacy and safety of GAL-101 eye…

Read More

Urgent Reminder from Faruqi & Faruqi: Class Action Lawsuit against Cardlytics with Lead Plaintiff Deadline Approaching – March 25, 2025

Faruqi & Faruqi, LLP: Investigating Potential Claims Against Cardlytics, Inc. Faruqi & Faruqi, LLP, a renowned securities law firm, is currently examining potential claims against Cardlytics, Inc. (Cardlytics or the Company) following the filing of a federal securities class action against the Company. The investigation focuses on the period between March 14, 2024, and August…

Read More

“Mark Your Calendars: Innoviz’s Q4 and Full Year 2024 Conference Call Scheduled for February 26th at 9:00 AM ET!”

Welcome to the Future of Automotive Safety with Innoviz Technologies Exciting News from Innoviz Technologies TEL AVIV, Israel, Feb. 7, 2025 /PRNewswire/ — Innoviz Technologies Ltd. (NASDAQ: INVZ), a leading Tier-1 direct supplier of high performance, automotive-grade LiDAR sensors and perception software, has recently announced that it will be releasing its earnings results for the…

Read More